Skip to Main Content

Paper Details

Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol
23
2019
Author NameAffiliation
Kathryn E FouldsVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael S SeamanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
David C MontefioriDuke Human Vaccine Institute, Duke University Medical Center
Raphael GottardoFred Hutchinson Cancer Research Center
Raphael GottardoFred Hutchinson Cancer Research Center
  • 1 - 5

Datasets

Release 1.2